Progenra partnered with Tokyo Medical University to develop inhibitors of rheumatoid arthritis target synoviolin (SYVN1; HRD1)

Progenra Inc.

U.S. / Private Biopharma

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Tokyo Medical University

Japan / Academic

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced